HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary P Wormser Selected Research

Post-Lyme Disease Syndrome

10/2021Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
1/2019Post-treatment Lyme disease symptoms score: Developing a new tool for research.
1/2018C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
12/2016Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.
12/2015Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
10/2011Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.
5/2011Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.
7/2009Antibiotic treatment of animals infected with Borrelia burgdorferi.
6/2009Implications of gender in chronic Lyme disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary P Wormser Research Topics

Disease

82Lyme Disease (Disease, Lyme)
01/2022 - 01/2002
30Infections
01/2022 - 06/2005
28Erythema
07/2021 - 07/2002
9Tick Bites
01/2022 - 06/2005
9Post-Lyme Disease Syndrome
10/2021 - 06/2009
8Babesiosis (Piroplasmosis)
01/2022 - 02/2008
7Fatigue
01/2018 - 07/2009
6Communicable Diseases (Infectious Diseases)
01/2022 - 07/2005
4Syphilis
04/2021 - 01/2020
4Pain (Aches)
02/2013 - 08/2010
3Relapsing Fever
04/2021 - 09/2016
3Malaria
01/2019 - 02/2008
2Facial Paralysis (Facial Palsy)
08/2018 - 08/2018
2Meningitis
08/2018 - 05/2003
2Thrombocytopenia (Thrombopenia)
02/2018 - 03/2013
2Headache (Headaches)
01/2018 - 03/2013
2Myocarditis (Carditis)
01/2017 - 01/2010
2Acquired Immunodeficiency Syndrome (AIDS)
09/2011 - 05/2011
2Arthritis (Polyarthritis)
01/2010 - 10/2002
2Ehrlichiosis
06/2005 - 07/2002
1Lymphadenopathy
04/2021
1COVID-19
12/2020
1Lyme Neuroborreliosis
09/2020
1Convalescence
01/2020
1Zika Virus Infection
09/2019
1Radiculopathy (Radiculopathy, Cervical)
08/2018
1Bell Palsy (Bell's Palsy)
08/2018
1Paralysis (Palsy)
08/2018
1Anemia
02/2018
1Neutropenia
02/2018
1Tick-Borne Encephalitis (Encephalitis, Tick Borne)
01/2018
1Arthralgia (Joint Pain)
01/2018
1Coinfection
01/2018
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2018
1Myalgia
01/2018
1Acute-Phase Reaction
12/2016
1Rheumatoid Arthritis
06/2016

Drug/Important Bio-Agent (IBA)

37Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 01/2002
16Doxycycline (Periostat)FDA LinkGeneric
01/2022 - 05/2003
14AntibodiesIBA
09/2021 - 01/2002
10EnzymesIBA
01/2022 - 04/2003
9Peptides (Polypeptides)IBA
01/2022 - 10/2002
8Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2013
8Immunoglobulin G (IgG)IBA
01/2020 - 04/2003
8Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2005
6Azithromycin (Zithromax)FDA LinkGeneric
01/2022 - 02/2008
6Immunoglobulin M (IgM)IBA
09/2021 - 04/2003
6Ceftriaxone (Ceftriaxon)FDA LinkGeneric
08/2018 - 01/2002
5AntigensIBA
01/2020 - 10/2002
5ImmunosorbentsIBA
01/2018 - 04/2003
51-oleoyl-2-stearoylphosphatidylcholineIBA
01/2013 - 05/2008
4Atovaquone (Mepron)FDA Link
01/2022 - 02/2008
4VaccinesIBA
01/2022 - 09/2011
4Amoxicillin (Wymox)FDA LinkGeneric
09/2019 - 04/2016
4CytokinesIBA
01/2017 - 10/2002
4EpitopesIBA
02/2016 - 07/2005
3InterferonsIBA
01/2021 - 12/2017
3cefuroxime axetil (Ceftin)FDA LinkGeneric
05/2019 - 01/2010
3Quinine (Quinson)FDA Link
04/2016 - 02/2008
3Clindamycin (Cleocin)FDA LinkGeneric
04/2016 - 02/2008
2OspA proteinIBA
01/2022 - 06/2005
2tafenoquineIBA
01/2022 - 01/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2020 - 01/2018
2Pharmaceutical PreparationsIBA
01/2019 - 02/2010
2C-Reactive ProteinIBA
01/2018 - 12/2016
2Rituximab (Mabthera)FDA Link
06/2016 - 02/2008
2Ribosomal DNA (rDNA)IBA
10/2008 - 09/2002
2OspC proteinIBA
10/2008 - 05/2008
1Penicillins (Penicillin)FDA Link
08/2020
1Glycerophospholipids (Phosphoglycerides)IBA
01/2020
1acylcarnitineIBA
01/2020
1Blood Proteins (Serum Proteins)IBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1EicosanoidsIBA
01/2020
1SphingolipidsIBA
01/2020
1Ivermectin (Mectizan)FDA Link
09/2019
1Anti-Infective Agents (Microbicides)IBA
05/2019
1VancomycinFDA LinkGeneric
05/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2018
1ORALIT (ORS)IBA
01/2018
1Antiviral Agents (Antivirals)IBA
01/2018
1Rifampin (Rifampicin)FDA LinkGeneric
11/2017
1Fatty Acids (Saturated Fatty Acids)IBA
08/2017
1AmidesIBA
08/2017
1Ethanolamine (Colamine)IBA
08/2017
1Serum Amyloid A Protein (Serum Amyloid A)IBA
12/2016
1A 7 (A-7)IBA
04/2016
1Borrelia burgdorferi VlsE proteinIBA
02/2016
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
02/2016
1AutoantigensIBA
12/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015

Therapy/Procedure

24Therapeutics
01/2021 - 01/2002
3Aftercare (After-Treatment)
01/2020 - 01/2010
3Blood Transfusion (Blood Transfusions)
08/2012 - 03/2011
2Antibiotic Prophylaxis
01/2018 - 06/2010
2Drug Therapy (Chemotherapy)
06/2016 - 02/2010
2Splenectomy
05/2011 - 03/2011
2Duration of Therapy
06/2005 - 07/2002
1Urinary Catheters
01/2022
1Erythrocyte Transfusion
02/2018